MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) are characterized by the presence of the BCR-ABL oncoprotein, which leads to activation of a plethora of mitogenic and pro-survival pathways, including the mTOR signaling cascade [144,145].